Genetic Testing Solution
Our Solution
The genetic testing market is growing rapidly, with more than 175,000 tests available today. Our Genetic Testing Management solution addresses the significant complexity that exists in genetic testing by ensuring that medical necessity criteria has been met for tests that may frequently be used inappropriately.
Matrix
- Genetic Tests and Laboratory Matrix - 4/1/24
2024 Genetic Testing Clinical Guidelines
- Genetic Testing: General Approach to Genetic Testing
- Genetic Testing: Aortopathies and Connective Tissue Disorders
- Genetic Testing: Cardiac Disorders
- Genetic Testing: Dermatologic Conditions
- Genetic Testing: Epilepsy, Neurodegerative and Neuromuscular Disorders
- Genetic Testing: Exome and Genome Sequencing for the Diagnosis of Genetic Disorders
- Genetic Testing: Eye Disorders
- Genetic Testing: Gastroenterologic Disorders (Non-Cancerous)
- Genetic Testing: Hearing Loss
- Genetic Testing: Hematologic Conditions (Non-Cancerous)
- Genetic Testing: Hereditary Cancer Susceptibility
- Genetic Testing: Immune, Autoimmune, and Rheumatoid Disorders
- Genetic Testing: Kidney Disorders
- Genetic Testing: Lung Disorders
- Genetic Testing: Metabolic, Endocrine, and Mitochondrial Disorder
- Genetic Testing: Multisystem Inherited Disorders, Intellectual Disability, and Developmental Delay
- Genetic Testing: Non-Invasive Prenatal Screening (NIPS)
- Genetic Testing: Pharmacogenetics
- Genetic Testing: Preimplantation Genetic Testing
- Genetic Testing: Prenatal and Preconception Carrier Screening
- Genetic Testing: Prenatal Diagnosis (Via Amniocentesis, CVS, or Pubs) and Pregnancy Loss
- Genetic Testing: Skeletal Dysplasia and Rare Bone Disorders
- Genetic Testing: Oncology - Algorithmic Testing
- Genetic Testing: Oncology - Cancer Screening
- Genetic Testing: Oncology - Circulating Tumor DNA and Circulating Tumor Cells (Liquid Biopsy)
- Genetic Testing: Oncology - Cytogenetic Testing
- Genetic Testing: Oncology - Molecular Analysis of Solid Tumors and Hematologic Malignancies